Tumor cells with an increased expression of the PD-1 ligand, PD-L1, are believed to escape host immunity through activation of the PD-1/PD-L1 pathway and the consequent suppression of effector immune responses [13,14,15,16]. The gene discussed is CD274; the disease is neoplasm.